政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/154600
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113656/144643 (79%)
Visitors : 51694589      Online Users : 410
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version
    政大典藏 > College of Law > Periodical Articles >  Item 140.119/154600


    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/154600


    Title: 由歐盟孤兒藥案件談競爭法與藥品超額定價問題
    EU Orphan Drug Cases and Tackling Excessive Drug Pricing by the Enforcement of Competition Law
    Authors: 魏杏芳
    Contributors: 法學院
    Keywords: UB測試;罕見疾病;孤兒藥;超額定價;銷售專屬權
    UB test;Rare disease;Orphan drug;Excessive pricing;Market exclusivity
    Date: 2023-06
    Issue Date: 2024-12-12
    Abstract: 由於孤兒藥的市場特性以及法定銷售專屬權保護，使藥廠有超額定價誘因，傷害了消費者及國家利益。近年歐盟數會員國接續對同一孤兒藥藥廠以違反競爭法裁罰，是為 Leadiant 案；歐盟執委會也查處安沛（Aspen）藥廠的血癌用藥，是否有違法超額定價情事，此顯示歐盟以競爭法介入藥價管制的趨勢。在個案中歐盟採「UB 測試」，即先「量」後「質」的分析模型，已具有通案性。歐盟競爭法設有禁止支配事業不公平定價的榨取式濫用條款，我國公平法亦有主旨相同的規範，歐盟的執法作為值得參考。
    The unique characteristics of orphan drug market and the right of exclusivity provide the incentives for pharmaceuticals to adopt excessive pricing. In recent years, three EU member states' competition authorities had fined the same orphan drug company, Leadiant, due to illegal excessive prices. European Commission also sanctioned Aspen because the medicine manufacture had imposed unfair prices, abused its dominant position and violated the EU competition law. All these facts reflect the trend that EU competition law has been used as a tool to tackle the exorbitantly high drug prices. The "UB test", i.e., cumulatively quantitative and qualitative analyses, is applied in those cases. The rules for prohibiting abuse of dominance in both EU and Taiwan have the common purposes and principles, therefore the practices and enforcement experiences in EU are valuable for use to learn.
    Relation: 月旦醫事法報告, No.80, pp.116-136
    Data Type: article
    DOI link: https://doi.org/10.53106/241553062023060080009
    DOI: 10.53106/241553062023060080009
    Appears in Collections:[College of Law] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML3View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback